SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence

[1]  F. Slack,et al.  Severe COVID-19 is associated with molecular signatures of aging in the human brain. , 2022, Nature aging.

[2]  Soyoung Lee,et al.  COVID-19 and cellular senescence , 2022, Nature reviews. Immunology.

[3]  B. Stripp,et al.  Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis , 2022, European Respiratory Journal.

[4]  Tokiko Watanabe,et al.  SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response , 2022, Nature Aging.

[5]  Chao Sui,et al.  SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy , 2022, The Journal of Immunology.

[6]  J. Shay,et al.  DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging , 2021, EMBO reports.

[7]  R. De Francesco,et al.  Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion , 2021, Science Immunology.

[8]  A. Poso,et al.  SARS‐CoV‐2–host proteome interactions for antiviral drug discovery , 2021, Molecular systems biology.

[9]  W. Travis,et al.  Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 , 2021, Science Translational Medicine.

[10]  Hongyan Huang,et al.  Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection , 2021, Biology direct.

[11]  Y. Mei,et al.  SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro , 2021, Viruses.

[12]  D. Bernard,et al.  Evidence That SARS-CoV-2 Induces Lung Cell Senescence: Potential Impact on COVID-19 Lung Disease , 2021, American journal of respiratory cell and molecular biology.

[13]  Z. Rao,et al.  Structural biology of SARS-CoV-2 and implications for therapeutic development , 2021, Nature Reviews Microbiology.

[14]  R. Eils,et al.  Virus-induced senescence is a driver and therapeutic target in COVID-19 , 2021, Nature.

[15]  Nimrat Chatterjee,et al.  SARS-CoV-2 triggers DNA damage response in Vero E6 cells , 2021, bioRxiv.

[16]  T. Pan,et al.  Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity , 2021, Nature Cell Biology.

[17]  M. Kohanski,et al.  SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes , 2021, Proceedings of the National Academy of Sciences.

[18]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[19]  R. Bartenschlager,et al.  Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication , 2021, Cell Reports.

[20]  G. Zimmer,et al.  A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets , 2021, bioRxiv.

[21]  Zhengfan Jiang,et al.  Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection , 2021, Signal Transduction and Targeted Therapy.

[22]  Jia Wang,et al.  SARS-CoV-2 nucleocapsid protein undergoes liquid–liquid phase separation into stress granules through its N-terminal intrinsically disordered region , 2021, Cell discovery.

[23]  Mark R. Marten,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 , 2021, Autophagy.

[24]  S. Moradi,et al.  In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection , 2020, Scientific Reports.

[25]  E. Lander,et al.  The SARS-CoV-2 RNA–protein interactome in infected human cells , 2020, Nature Microbiology.

[26]  D. Baker,et al.  Cellular senescence in ageing: from mechanisms to therapeutic opportunities , 2020, Nature Reviews Molecular Cell Biology.

[27]  Nicolas L. Fawzi,et al.  SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs , 2020, The EMBO journal.

[28]  L. Zentilin,et al.  Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology , 2020, EBioMedicine.

[29]  V. Thiel,et al.  Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.

[30]  S. Chanda,et al.  SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling , 2020, Proceedings of the National Academy of Sciences.

[31]  M. Guttman,et al.  SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses , 2020, Cell.

[32]  J. Lou,et al.  Liquid–liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA , 2020, Cell Research.

[33]  D. A. Stein,et al.  TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells , 2020, Life Science Alliance.

[34]  Andrew R. Leach,et al.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.

[35]  Eugene V. Koonin,et al.  Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses , 2020, Proceedings of the National Academy of Sciences.

[36]  R. Schwartz,et al.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.

[37]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[38]  B. Deplancke,et al.  Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium , 2020, bioRxiv.

[39]  Hyeshik Chang,et al.  The Architecture of SARS-CoV-2 Transcriptome , 2020, Cell.

[40]  F. d’Adda di Fagagna,et al.  Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage response factors , 2019, Nature Cell Biology.

[41]  V. Gottifredi,et al.  Chk1 loss creates replication barriers that compromise cell survival independently of excess origin firing , 2019, The EMBO journal.

[42]  M. Altmeyer,et al.  Phase separation of 53BP1 determines liquid‐like behavior of DNA repair compartments , 2019, The EMBO journal.

[43]  S. Francia,et al.  Pharmacological boost of DNA damage response and repair by enhanced biogenesis of DNA damage response RNAs , 2019, Scientific Reports.

[44]  A. Venkitaraman,et al.  BRCA2 controls DNA:RNA hybrid level at DSBs by mediating RNase H2 recruitment , 2018, Nature Communications.

[45]  Zhijian J. Chen,et al.  The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer , 2018, The Journal of experimental medicine.

[46]  Younho Choi,et al.  Autophagy during viral infection — a double-edged sword , 2018, Nature Reviews Microbiology.

[47]  G. Shivashankar,et al.  Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks , 2017, Nature Cell Biology.

[48]  Dennis E Discher,et al.  Mitotic progression following DNA damage enables pattern recognition within micronuclei , 2017, Nature.

[49]  Jessica K De Freitas,et al.  WRN regulates pathway choice between classical and alternative non-homologous end joining , 2016, Nature Communications.

[50]  G. Lenzi,et al.  HPV31 utilizes the ATR-Chk1 pathway to maintain elevated RRM2 levels and a replication-competent environment in differentiating Keratinocytes. , 2016, Virology.

[51]  J. Mikkelsen,et al.  Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection , 2016, Hepatology.

[52]  Marco Y. Hein,et al.  p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1 , 2016, Proceedings of the National Academy of Sciences.

[53]  H. Qi,et al.  ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG. , 2016, Biochimica et biophysica acta.

[54]  R. Hollingworth,et al.  Activation of the DNA Damage Response by RNA Viruses , 2016, Biomolecules.

[55]  Honglin Luo.  Interplay between the virus and the ubiquitin–proteasome system: molecular mechanism of viral pathogenesis , 2015, Current Opinion in Virology.

[56]  F. d’Adda di Fagagna,et al.  Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing , 2014, Current opinion in genetics & development.

[57]  D. Green,et al.  To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate , 2014, Cell.

[58]  Michal Zimmermann,et al.  53BP1: pro choice in DNA repair. , 2014, Trends in cell biology.

[59]  Benjamin G. Bitler,et al.  Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. , 2013, Cell reports.

[60]  R. Grand,et al.  DNA viruses and the cellular DNA-damage response. , 2012, The Journal of general virology.

[61]  P. Reichard,et al.  Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells , 2012, Proceedings of the National Academy of Sciences.

[62]  Piero Carninci,et al.  Site-specific DICER and DROSHA RNA products control the DNA damage response , 2012, Nature.

[63]  F. D. D. Fagagna,et al.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.

[64]  S. Jackson,et al.  Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. , 2011, Genes & development.

[65]  C. Lilley,et al.  Genomes in conflict: maintaining genome integrity during virus infection. , 2010, Annual review of microbiology.

[66]  C. Lilley,et al.  A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses , 2010, The EMBO journal.

[67]  P. Reichard,et al.  Quantitation of cellular deoxynucleoside triphosphates , 2009, Nucleic acids research.

[68]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[69]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[70]  H. Niida,et al.  Essential role of Chk1 in S phase progression through regulation of RNR2 expression. , 2008, Biochemical and biophysical research communications.

[71]  F. D. D. Fagagna.  Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.

[72]  C. Lilley,et al.  Using or abusing: viruses and the cellular DNA damage response. , 2007, Trends in microbiology.

[73]  A. Amsterdam,et al.  DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. , 2006, Genes & development.

[74]  S. Bekker-Jensen,et al.  Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1 , 2005, The Journal of cell biology.

[75]  Ying Zhu,et al.  Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus , 2005, Virus Research.

[76]  C. McCall,et al.  Targeted ubiquitination of CDT1 by the DDB1–CUL4A–ROC1 ligase in response to DNA damage , 2004, Nature Cell Biology.

[77]  J. Gautier,et al.  Regulation of DNA replication by ATR: signaling in response to DNA intermediates. , 2004, DNA repair.

[78]  Jianyu Zheng,et al.  Radiation-mediated proteolysis of CDT1 by CUL4–ROC1 and CSN complexes constitutes a new checkpoint , 2003, Nature Cell Biology.

[79]  Jeffrey M. Trimarchi,et al.  Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.

[80]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.